These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26341695)

  • 81. A Programmed Nanoparticle with Self-Adapting for Accurate Cancer Cell Eradication and Therapeutic Self-Reporting.
    Luo Y; Huang L; Yang Y; Zhuang X; Hu S; Ju H; Yu BY; Tian J
    Theranostics; 2017; 7(5):1245-1256. PubMed ID: 28435462
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evolving Important Role of Lutetium-177 for Therapeutic Nuclear Medicine.
    Pillai AM; Knapp FF
    Curr Radiopharm; 2015; 8(2):78-85. PubMed ID: 25771380
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Theranostic Role of
    Galiè M; Boschi F; Scambi I; Merigo F; Marzola P; Altabella L; Lavagnolo U; Sbarbati A; Spinelli AE
    Theranostics; 2017; 7(18):4399-4409. PubMed ID: 29158835
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Preparation of Radioactive Skin Patches Using Polyhydroxamic Acid-Grafted Cellulose Films Toward Applications in Treatment of Superficial Tumors.
    Saxena SK; Kumar Y; Shaikh SH; Pandey U; Kumar SA; Dash A
    Cancer Biother Radiopharm; 2017 Dec; 32(10):364-370. PubMed ID: 29265920
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT).
    Grzmil M; Boersema P; Sharma A; Blanc A; Imobersteg S; Pruschy M; Picotti P; Schibli R; Behe M
    J Hematol Oncol; 2022 Aug; 15(1):123. PubMed ID: 36045419
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Nanoparticle-based hyperthermia, a local treatment modulating the tumor extracellular matrix.
    Kolosnjaj-Tabi J; Marangon I; Nicolas-Boluda A; Silva AKA; Gazeau F
    Pharmacol Res; 2017 Dec; 126():123-137. PubMed ID: 28720518
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical Best Practices for Radiation Safety During Lutetium-177 Therapy.
    Cappon DJ; Fang S; Berry K; Capone G; Carlton GL; Chrétien M; Gough J; Kamen J; Khoorshed A; Miller A; Nelli S; Petric MP; Tourneur F; Zic JJ
    Health Phys; 2023 Feb; 124(2):139-146. PubMed ID: 36508552
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Synthesis and targeting of gold-coated
    Sobol N; Sutherlin L; Cedrowska E; Schorp J; Rodríguez-Rodríguez C; Sossi V; Lattimer J; Miller DC; Pevsner P; Robertson JD
    APL Bioeng; 2018 Mar; 2(1):016101. PubMed ID: 31069286
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Shaping Tumor Microenvironment for Improving Nanoparticle Delivery.
    Gao H
    Curr Drug Metab; 2016; 17(8):731-736. PubMed ID: 27396754
    [TBL] [Abstract][Full Text] [Related]  

  • 90. How does the cell overcome LCP nanoparticle-induced calcium toxicity?
    Tseng YC; Yang A; Huang L
    Mol Pharm; 2013 Nov; 10(11):4391-5. PubMed ID: 24032396
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Radio-enhancement effects by radiolabeled nanoparticles.
    Gholami YH; Maschmeyer R; Kuncic Z
    Sci Rep; 2019 Oct; 9(1):14346. PubMed ID: 31586146
    [TBL] [Abstract][Full Text] [Related]  

  • 92. NaCl Nanoparticles as a Cancer Therapeutic.
    Jiang W; Yin L; Chen H; Paschall AV; Zhang L; Fu W; Zhang W; Todd T; Yu KS; Zhou S; Zhen Z; Butler M; Yao L; Zhang F; Shen Y; Li Z; Yin A; Yin H; Wang X; Avci FY; Yu X; Xie J
    Adv Mater; 2019 Nov; 31(46):e1904058. PubMed ID: 31553099
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Modelling of the
    Bhardwaj R; Wolterbeek HT; Denkova AG; Serra-Crespo P
    Appl Radiat Isot; 2020 Dec; 166():109261. PubMed ID: 32961525
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cancer theranostics with ⁶⁴Cu/¹⁷⁷Lu-loaded liposomes.
    Ehlerding EB; Goel S; Cai W
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):938-940. PubMed ID: 26743898
    [No Abstract]   [Full Text] [Related]  

  • 95. Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents.
    Casini A; Orvig C; Correia JDG
    Dalton Trans; 2017 Oct; 46(42):14433-14434. PubMed ID: 29057999
    [No Abstract]   [Full Text] [Related]  

  • 96. Characterization and Efficacy of a Nanomedical Radiopharmaceutical for Cancer Treatment.
    Yao Mattisson I; Bäckström S; Ekengard E; Lekmeechai S; Liu YC; Paris J; Petoral R; Sydoff M; Hansen M; Axelsson O
    ACS Omega; 2023 Jan; 8(2):2357-2366. PubMed ID: 36687034
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Bacteriophage Associated Silicon Particles: Design and Characterization of a Novel Theranostic Vector with Improved Payload Carrying Potential.
    Srinivasan S; Alexander JF; Driessen WH; Leonard F; Ye H; Liu X; Arap W; Pasqualini R; Ferrari M; Godin B
    J Mater Chem B; 2013 Oct; 1(39):. PubMed ID: 24409342
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment.
    Siveke JT
    J Nucl Med; 2018 Sep; 59(9):1412-1414. PubMed ID: 30097504
    [No Abstract]   [Full Text] [Related]  

  • 99. Correction to "Targeted Theranostic
    Cheng MHY; Overchuk M; Rajora MA; Lou JWH; Chen Y; Pomper MG; Chen J; Zheng G
    Mol Pharm; 2023 Jan; 20(1):783. PubMed ID: 36351175
    [No Abstract]   [Full Text] [Related]  

  • 100. Nanoparticle Delivered VEGF-A siRNA Enhances Photodynamic Therapy for Head and Neck Cancer Treatment.
    Lecaros RL; Huang L; Lee TC; Hsu YC
    Mol Ther; 2016 Feb; 24(1):106-16. PubMed ID: 26373346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.